跳至主要内容
临床试验/NCT01857050
NCT01857050已完成不适用

Assessment of INR Prolongation in Patients Treated Simultaneously With Warfarin and Antibiotics From the Cephalosporins Family,Observational Retrospective Study.

Meir Medical Center0 个研究点目标入组 236 人开始时间: 2013年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
236
主要终点
Reasons for INR prolongation in patients who were treated with the combination of Warfarin and Cephalosporins

研究概览

简要总结

Many drug interactions with Warfarin are well documented in the literature, including interactions with a variety of antibiotics. However,in mamy cases it is difficult to predict when the interaction remains theoretical and when it becomes clinically significant and will be reflected in the individual patient. This study's aim is to identify and characterize related conditions (including comorbidities, laboratory test results and other parameters related to the patient)that might be predictors for drug interactions turning from theoretical to clinically significant.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 18 and over
  • Patients treated with a combination of Warfarin and Cephalosporins
  • Patients who were hospitalized in the department of internal medicine
  • Patients who were treated with Warfarin without Cefalosporins

排除标准

  • Patients on Warfarin who did not actually receive the drug during their hospitalization
  • Patients whose medical records were not accessible or didn't contain full data

结局指标

主要结局

Reasons for INR prolongation in patients who were treated with the combination of Warfarin and Cephalosporins

时间窗: Participants will be followed for the duration of thei hospital stay, an expected average of 7 days

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验